Skip to main content

Table 3 Uptake of indicators of continuous care and other characteristics of accessibility of care for people living with HIV on ART according to HIV-acquisition risk

From: Measuring the uptake of continuous care among people living with HIV receiving antiretroviral therapy and social determinants of the uptake of continuous care in the southwest of China: a cross-sectional study

  Total (n = 702) HIV-acquisition risk category p value
Heterosexuals (n = 239) MSM (n = 231) PWID (n = 232)
Indicators of continuous care (%)
 Adequate routine visit 82.9 77.0 87.9 84.1 0.006
 Adequate routine test 81.9 80.8 85.7 79.3 0.171
 Adequate CD4 testing 80.6 80.8 87.0 74.1 0.002
 Adequate viral load testing 15.8 15.9 23.8 7.8  < 0.001
 Mental health assessment 15.0 15.9 23.8 7.8  < 0.001
 Mental health counselling 30.8 20.9 31.6 40.1  < 0.001
 BMD measurement 36.5 40.2 46.3 22.8  < 0.001
 CKD risk evaluation 84.8 91.6 94.4 68.1  < 0.001
 CVD risk monitoring 84.6 93.7 89.2 70.7  < 0.001
 ECG 71.1 74.5 71.0 67.7 0.265
 TB screening 93.3 98.7 95.7 85.3  < 0.001
 HBV serological test 63.5 62.8 73.6 54.3  < 0.001
 HCV serological test 70.4 59.4 68.4 83.6  < 0.001
 Syphilis serological test 51.0 53.1 60.6 39.2  < 0.001
Other characteristics of accessibility of care
 Chronic comorbidities (%) 39.2 18.0 13.0 87.1  < 0.001
 Distance to HIV facilities, (kilometers) 10.0 (5.0,30.0) 11.0 (7.0,40.0) 10.0 (5.0, 20.0) 10.0 (5.0, 30.0) 0.005
 Travel time, (hour) 0.7 (0.5,1.0) 1.0 (0.5,1.5) 0.5 (0.5,1.0) 0.7 (0.3,1.0)  < 0.001
 Transportation fee, (yuan) 6.0 (2.2,20.0) 6.0 (2.0,23.5) 10.0 (3.0,20.0) 5.0 (2.0,20.0) 0.310
 Waiting time for getting medicine, (hour) 1.0 (0.7,2.0) 1.5 (1.0, 2.0) 1.5 (1.0, 2.0) 1.0 (0.5,2.0)  < 0.001
 ART duration, (years) 3.7 (2.1, 4.7) 3.8 (2.2, 4.6) 3.0 (1.6, 4.4) 4.1 (2.7, 4.7)  < 0.001
  1. Data are column percentage or median (IQR). MSM men who have sex with men, PWID people who inject drugs, CKD chronic kidney diseases, CVD cardiovascular diseases, TB tuberculosis, ECG electrocardiogram, HBV/HCV hepatitis B/C virus